Generation of PRL-3- and PRL-1-specific monoclonal antibodies as potential diagnostic markers for cancer metastases
about
VHZ is a novel centrosomal phosphatase associated with cell growth and human primary cancersMetastasis-associated PRL-3 induces EGFR activation and addiction in cancer cellsPRL-3, a metastasis associated tyrosine phosphatase, is involved in FLT3-ITD signaling and implicated in anti-AML therapyPhosphatase of regenerating liver-3 localizes to cyto-membrane and is required for B16F1 melanoma cell metastasis in vitro and in vivoA role of autophagy in PTP4A3-driven cancer progression.Phosphatase of regenerating liver: a novel target for cancer therapy.Independent oncogenic and therapeutic significance of phosphatase PRL-3 in FLT3-ITD-negative acute myeloid leukemia.PRL-3 suppresses c-Fos and integrin α2 expression in ovarian cancer cells.Expression of phosphatase of regenerating liver family genes during embryogenesis: an evolutionary developmental analysis among Drosophila, amphioxus, and zebrafishMembrane protein CNNM4-dependent Mg2+ efflux suppresses tumor progressionEngineering the first chimeric antibody in targeting intracellular PRL-3 oncoprotein for cancer therapy in mice.Mechanisms regulating colorectal cancer cell metastasis into liver (Review).PRL-3 activates mTORC1 in Cancer Progression.Overexpression and involvement in migration by the metastasis-associated phosphatase PRL-3 in human myeloma cellsExpression of phosphatase regenerating liver 3 is an independent prognostic indicator for gastric cancerOncogenic roles of PRL-3 in FLT3-ITD induced acute myeloid leukaemia.PRL3-zumab, a first-in-class humanized antibody for cancer therapy.Role of phosphatase of regenerating liver 1 (PRL1) in spermatogenesis.Phosphatase of regenerating liver 2 (PRL2) deficiency impairs Kit signaling and spermatogenesis.PRL-3 phosphatase and cancer metastasis.The metastasis-associated gene Prl-3 is a p53 target involved in cell-cycle regulation.Phosphatase of regenerating liver in hematopoietic stem cells and hematological malignancies.Targeting intracellular oncoproteins with antibody therapy or vaccination.Phosphatase PRL-3 is a direct regulatory target of TGFbeta in colon cancer metastasis.Suppression of breast tumor growth by DNA vaccination against phosphatase of regenerating liver 3.Increased expression of PRL-1 protein correlates with shortened patient survival in human hepatocellular carcinoma.Expression of phosphatase of regenerating liver (PRL)-3, is independently associated with biochemical failure, clinical failure and death in prostate cancer.Expression of Phosphatase Regenerating Liver-1 in Esophageal Squamous Cell Carcinoma Associated with Metastasis
P2860
Q21093278-EFD1FD25-3D00-4876-8D33-DAD1EE88CA29Q27852452-604560D8-5CF8-4EF8-B9D5-A8FB68AD91B6Q28388468-6B968DD9-4953-4EF9-9052-16360B73A21BQ33408806-4E2A2DDD-2934-4AD2-84C0-FDAB14D415A4Q34344700-7B4C4A2F-A4A6-4C10-BABE-C4B5B34BF7AFQ34437541-8334AD9B-9EDF-470B-87BC-2541D5532564Q34507306-85BFED5D-39E5-4261-AFE4-C56D22B413B3Q34590459-DD789E54-033B-48DC-B3E4-37E6F453E527Q34704624-349D65F8-99D4-4387-9AF1-74844CB7BA95Q35145340-078C2826-51FD-47A3-82EE-217F61F5BC62Q35889827-D87FFB70-7768-4A82-BD46-50E74D199795Q35995311-647DD508-1D13-48AF-9D15-E78F5B133B54Q36310169-EF95D0A2-B403-4707-A7BC-07E2F2E778CFQ36384761-E0AA9503-653D-4DA5-881B-3F67D3099787Q37149601-F1D259A4-9099-437E-AAB3-30A2C35CD651Q37236903-94B721C2-F170-410F-94A8-2898295570C4Q37277211-FF35B015-CAB9-4A80-B502-E18D46237532Q37281658-5A5C18BA-B4EE-4EE6-9096-F2D90DF32FE6Q37563586-49F0B213-2AEE-476C-994A-0078072B73B9Q37807363-DE5DA635-36BF-4871-B179-40E6B35B23CDQ38261521-C22ACCB7-8B19-4354-BCDD-65F86F6373A7Q38285175-729AFFE8-1175-4E35-99D9-5DE8AD7BD46BQ39477768-F9BAB3A0-5B0C-42F6-8E1C-D510492BD7D4Q39630626-0B0526C2-9BFA-46F4-B896-344212A4CE1DQ43522873-1DA83CBF-4FAE-47A0-A21D-A0776327A438Q44320637-74452FD2-32F5-4279-B26F-976032568AD9Q47123783-78676A0A-DA71-44D4-BC5B-9408F8BF1714Q58689969-9578B5D9-41BF-42E6-9DCC-563C226B5258
P2860
Generation of PRL-3- and PRL-1-specific monoclonal antibodies as potential diagnostic markers for cancer metastases
description
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2005
@ast
im März 2005 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: 15 March 2005)
@en
vedecký článok (publikovaný 2005/03/15)
@sk
vědecký článek publikovaný v roce 2005
@cs
wetenschappelijk artikel (gepubliceerd op 2005/03/15)
@nl
наукова стаття, опублікована в березні 2005
@uk
مقالة علمية (نشرت في 15-3-2005)
@ar
name
Generation of PRL-3- and PRL-1 ...... markers for cancer metastases
@ast
Generation of PRL-3- and PRL-1 ...... markers for cancer metastases
@en
Generation of PRL-3- and PRL-1 ...... markers for cancer metastases
@nl
type
label
Generation of PRL-3- and PRL-1 ...... markers for cancer metastases
@ast
Generation of PRL-3- and PRL-1 ...... markers for cancer metastases
@en
Generation of PRL-3- and PRL-1 ...... markers for cancer metastases
@nl
prefLabel
Generation of PRL-3- and PRL-1 ...... markers for cancer metastases
@ast
Generation of PRL-3- and PRL-1 ...... markers for cancer metastases
@en
Generation of PRL-3- and PRL-1 ...... markers for cancer metastases
@nl
P2093
P3181
P1476
Generation of PRL-3- and PRL-1 ...... markers for cancer metastases
@en
P2093
Bin Qi Gan
Hui Xiang Li
Jing Ping Tang
Vicki Wei Chyi Koh
P304
P3181
P356
10.1158/1078-0432.CCR-04-1984
P407
P577
2005-03-15T00:00:00Z